Skip Navigation


European Heart Journal Advance Access originally published online on October 11, 2007
European Heart Journal 2007 28(21):2653-2660; doi:10.1093/eurheartj/ehm427
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/21/2653    most recent
ehm427v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Woodward, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woodward, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region

Mark Woodward*, Federica Barzi, Valery Feigin, Dongfeng Gu, Rachel Huxley, Koshi Nakamura, Anushka Patel, Suzanne Ho, Konrad Jamrozik for the Asia Pacific Cohort Studies Collaboration

Received 30 March 2007; revised 13 August 2007; accepted 31 August 2007; online publish-ahead-of-print 11 October 2007.

* Corresponding author. Mark Woodward, Department of Medicine, One Gustave L. Levy Place, P.O. Box 1087, New York, NY 10029-6574, USA. Tel: +1 212 241 5451; fax: +1 212 831 8116. E-mail address: mwoodward{at}george.org.au

Background: The inverse relationship between high-density lipoprotein (HDL) cholesterol and coronary heart disease (CHD) is well established. Questions remain about the association between HDL cholesterol and stroke, particularly for stroke subtypes.

Methods and results: Cox survival models were applied to individual participant data from 25 cohort studies (about 80 000 subjects), with a median of 6.8 years follow-up. After adjustment for age and regression dilution, hazard ratios (95% confidence intervals) for a 1 standard deviation (SD) lower level of HDL cholesterol (0.4 mmol/L) were: for CHD events, 1.39 (1.22–1.57); for ischaemic stroke, 0.90 (0.75–1.07), and for haemorrhagic stroke, 0.89 (0.74–1.07). As total cholesterol (TC) increased relative to HDL cholesterol, the risk of CHD increased, the risk of ischaemic stroke was unchanged but the risk of haemorrhagic stroke decreased. A 1 SD increase in TC/HDL cholesterol (1.63 units) was associated with a 27% decrease in the risk of haemorrhagic stroke (95% confidence interval, 7–44%).

Conclusion: There is clear evidence of potential benefit for CHD of increases in HDL cholesterol and decreases in TC relative to HDL cholesterol, but no evidence of an association between either HDL cholesterol or TC/HDL cholesterol and ischaemic stroke. Increasing HDL cholesterol relative to TC may increase the risk of haemorrhagic stroke.

Key Words: Cholesterol • Coronary disease • Stroke • Lipids


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.